雌激素与人类怀孕的关联与细胞染色体P450 3A活动的相关增加有关
Muluneh M Fashe1, Jonghwa Lee1, Joseph T Grieco1
1Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Frontiers in pharmacology
|December 12, 2025
概括
怀孕会通过CYP3A酶增加药物代谢. 这项研究发现,怀孕期间雌激素 (E1) 和雌激醇 (E2) 的水平升高与较高的CYP3A活性相关,这表明它们驱动了这些变化.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 在怀孕期间,由于CYP3A活性升高,药物清除率可能会增加,这可能导致药物水平低于治疗水平.
- 已知与怀孕相关的激素 (PRHs) 会增加CYP3A4的表达和活性,但具体的循环因素仍不清楚.
研究的目的:
- 调查孕期母体血中类固醇PRH和CYP3A活性生物标志物度之间的关联.
- 为了确定个别PRHs对人类原发性肝细胞中CYP3A4表达的影响.
主要方法:
- 量化了雌激素 (E1),雌激醇 (E2),孕 (P4),皮质醇 (CRT) 和CYP3A活性生物标志物的血度 (4β-基胆固醇及其与胆固醇的比率).
- 分析了来自非孕妇对照组,健康孕妇志愿者和孕前患者的血样本.
- 评估了E1,E2,P4和CRT对培养人类肝细胞中的CYP3A4mRNA和蛋白质表达的影响.
主要成果:
- 血4β-基胆固醇度,一个CYP3A活性生物标志物,与非孕妇对照相比,在孕妇中显著更高.
- 血E1和E2度与孕妇中的4β-氧胆固醇水平呈正相关.
- 在体外,E1和E2暴露增加了CYP3A4mRNA和总CYP3A蛋白,以度依赖的方式.
结论:
- 母体循环中的雌激素 (E1) 和雌激醇 (E2) 度升高,导致人类怀孕期间肝脏CYP3A的表达和活性增加.
相关概念视频
02:07Oogenesis
68.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.8K
01:24Gonadal and Placental Hormones
2.7K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
2.7K
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
01:22Hormonal Regulation of the Menstrual Cycle
1.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
01:19Factors Affecting Drug Biotransformation: Biological
497
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
497
01:17Drug Metabolism: Phase I Reactions
4.5K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.5K